Physicians Formula Holdings, Inc. (NASDAQ:FACE)

CAPS Rating: No stars 0.00

The Company develops, markets, manufactures and distributes innovative, premium-priced products for the mass market channel.

Caps

How do you think FACE will perform against the market?

Add Stock to CAPS Watchlist

All Players

22 Outperform
8 Underperform
 

All-Star Players

6 Outperform
1 Underperform
 

Wall Street

2 Outperform
1 Underperform
 

Top FACE Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

NetscribeConsGds (96.77)
Submitted March 12, 2007

Physicians Formula (FACE) is one of the fastest growing cosmetics companies operating in the mass-market prestige (Masstige). The company markets innovative and premium priced products for the mass-market channel. Its products address specific,… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

FACE VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about FACE.

Recs

0
Member Avatar WordTickers (67.59) Submitted: 5/31/2008 12:21:06 PM : Outperform Start Price: $8.36 FACE Score: -156.00

Testing out a portfolio with outperforms on stocks with tickers that spell words.

Recs

0
Member Avatar doveld (< 20) Submitted: 5/30/2008 9:29:29 AM : Underperform Start Price: $9.76 FACE Score: +155.63

Going short...has been on the decline even thru last year's boom..economic contraction will magnify the woes.

Recs

1
Member Avatar NetscribeConsGds (96.77) Submitted: 3/12/2007 8:04:36 AM : Outperform Start Price: $20.24 FACE Score: -186.79

Physicians Formula (FACE) is one of the fastest growing cosmetics companies operating in the mass-market prestige (Masstige). The company markets innovative and premium priced products for the mass-market channel. Its products address specific, everyday cosmetics needs and include face powders, bronzers, concealers, blushes, foundations, eye shadows, eye liners, brow makeup and mascaras.

The $2.8 billion face makeup and $2.5 billion eye makeup market has been on a rise with a compounded annual growth rate of 3.0% and 5.9% respectively since 2000. The business of selling cosmetic is highly competitive with companies competing on the basis of market share and product innovation. More importantly, FACE through its continuous product innovation has been able to gain substantial Masstige market share and has established a foothold of 12.7% and 5.2% respectively till November 2006. The company’s innovation spree is reflected from the fact that its new products contributed 33% to the total net sales for Q3’06.

FACE has been consistently broadening its total distribution, which has ensured a top-line growth of 29.5% for Q3’06. The company’s ability to differentiate its product as solution for skin imperfections would help them to be less affected by dramatic changes in fashion trends. The company continues to expand its presences in the mass-market channel in the U.S. and abroad has resulted in rapid growth in their customer base.

The company’s focus on developing new products coupled with promotional activities to support these innovations should enable the company to gain additional shelf space during its peak fourth and first quarter. The company’s potential to enhance its revenue through product innovation should be reflected in its bottom-line, which would enhance the shareholders value in the coming year.

Leaderboard

Find the members with the highest scoring picks in FACE.

Score Leader

kkubek

kkubek (64.12) Score: +180.95

The Score Leader is the player with the highest score across all their picks in FACE.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
kkubek 64.12 3/26/2007 Underperform NS $19.84 -75.30% +105.65% +180.95 0 Comment
OtionAmarante < 20 4/23/2007 Underperform NS $21.02 -76.68% +98.90% +175.58 0 Comment
stupa < 20 12/3/2007 Underperform 3M $12.91 -62.03% +97.35% +159.38 0 Comment
doveld < 20 5/30/2008 Underperform 1Y $9.76 -49.79% +105.84% +155.63 1 Comment
Runsinthewynd 75.34 7/11/2007 Underperform 5Y $11.93 -58.94% +94.91% +153.85 0 Comment
rfields576 71.96 8/14/2007 3/6/2008 Underperform 3Y $9.68 -49.38% +104.06% +153.44 0 Comment
SanDieguito 25.52 7/10/2007 Underperform NS $11.80 -58.46% +94.53% +152.99 0 Comment
institutionsup < 20 6/22/2010 Outperform 5Y $3.57 +37.11% +150.55% -113.45 0 Comment
oregonwine < 20 6/16/2010 Outperform NS $3.68 +33.22% +150.53% -117.31 0 Comment
lionstan 90.05 9/19/2007 Outperform 5Y $11.74 -58.28% +90.74% -149.02 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackPiperJaff 85.27 6/16/2010 Underperform NS $3.68 +33.22% +150.53% +117.31 0 Comment
TrackCitigroup 91.85 8/20/2007 Outperform NS $10.49 -81.89% -37.28% -44.61 5/12/2009 @ $1.90 0 Comment
TrackWellsFargo 86.46 5/18/2007 Outperform NS $18.03 -47.48% -4.25% -43.23 8/14/2007 @ $9.47 0 Comment
TrackPiperJaff 85.27 12/20/2006 Outperform NS $18.41 -62.47% -9.19% -53.28 8/22/2008 @ $6.91 0 Comment
TrackDeutscheSec 85.75 12/19/2006 Outperform NS $18.67 -73.76% +109.49% -183.25 0 Comment
TrackCowenandCo 77.74 12/19/2006 Outperform NS $18.67 -73.76% +109.49% -183.25 0 Comment

Advertisement